ICD-10-CM Billable Code

H35.149

Retinopathy of prematurity, stage 3, unspecified eye

Clinical Classification Guidelines

Medical Intelligence & Overview

Retinopathy of prematurity (ROP) is a condition that affects the developing retina of premature infants. Stage 3 ROP is a more advanced form that involves significant abnormal blood vessel growth in the retina, which may potentially lead to vision impairment or blindness if not properly managed. This article provides an overview of stage 3 ROP, including its causes, symptoms, diagnosis, and treatment options.

Causes & Symptoms

Clinical Causes: Premature birth, especially before 31 weeks of gestation Low birth weight, typically less than 1500 grams (3 pounds, 4 ounces) High levels of oxygen therapy administered to premature infants during neonatal care Genetic predisposition affecting blood vessel development in the retina Medical complications associated with prematurity, such as respiratory distress or infections

Key Symptoms: No obvious symptoms in early stages; often diagnosed during routine eye examinations Increased blinking or eye discomfort in advanced cases Abnormal eye movements or strabismus (crossed eyes) Leukocoria (white reflection from the retina) observed in some cases Potential signs of visual impairment as the condition progresses

Diagnostic & Treatment

Diagnosis Path: Diagnosis of stage 3 ROP is primarily made through a thorough eye examination by a pediatric ophthalmologist. The evaluation includes:

Treatment Protocols: Treatment aims to prevent progression of abnormal blood vessel growth and preserve vision. Options include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H35.149 a billable ICD-10 code?
Yes, H35.149 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H35.149?
Clinical documentation must specify the nature of Retinopathy of prematurity, stage 3, unspecified eye and any associated comorbidities for accurate reporting.

Cite this Clinical Reference